Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 8/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24201501 | 0.92 | HSD17B3 (0.67) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL22102183 | 0.83 | HSD17B3 (0.71) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL19014017 | 0.82 | HSD17B3 (0.60) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL19404981 | 0.81 | HSD17B3 (0.64) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL27273811 | 0.81 | HSD17B3 (0.60) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL24923962 | 0.81 | TSHR (0.43) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL24385889 | 0.80 | HSD17B3 (0.61) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL29292330 | 0.79 | HSD17B3 (0.57) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL26023127 | 0.78 | HSD17B3 (0.56) | HSD17B3TSHRNOTUMMAPTMEN1 | |
| SCHEMBL25124359 | 0.78 | HSD17B3 (0.59) | HSD17B3TSHRNOTUMMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | HSD17B3 1455/4885TSHR 3267/4885NOTUM 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.